SPI1 affects Aβ1-42-induced microglia-mediated neuroinflammation by transcriptionally regulating FOSL2 expression

Jing Du1, ZeXin An2

  • 1Department of Neurology, The First Affiliated Hospital of Hebei North University, Zhangjiakou City, Hebei Province, China.

PubMed
Abstract

Insights

Knocking down SPI1 promotes M2 microglia polarization, reducing neuroinflammation and potentially slowing Alzheimer's disease progression by inhibiting the FOSL2/JAK2/STAT3 pathway.

Area of Science:

  • Neuroscience
  • Immunology
  • Molecular Biology

Background:

  • Microglia-driven neuroinflammation is a key factor in Alzheimer's disease (AD) progression.
  • SPI1 is linked to neuroinflammation and neuronal function in AD, but its precise role is unclear.

Purpose of the Study:

  • To elucidate the mechanism of SPI1 in microglia-induced neuroinflammation in Alzheimer's disease.

Main Methods:

  • Established an Alzheimer's disease cell model using BV2 cells and Aβ1-42.
  • Assessed inflammatory factors, cellular morphology, gene/protein expression (ELISA, Western blot, RT-qPCR, IF).
  • Investigated SPI1-FOSL2 interaction using dual luciferase and ChIP assays.

Main Results:

  • SPI1 and FOSL2 expression increased in Aβ1-42-induced BV2 cells.
  • Knockdown of SPI1 or FOSL2 promoted M2 microglia polarization.
  • SPI1 promotes FOSL2 expression by binding to its promoter, inactivating the JAK2/STAT3 pathway.

Conclusions:

  • SPI1 knockdown enhances M2 microglia polarization, suppressing neuroinflammation.
  • This suppression occurs via the FOSL2/JAK2/STAT3 pathway, potentially alleviating Alzheimer's disease progression.